Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Gordon Strathdee.
Newcastle Authors
Title
Year
Full text
Chalermsin Permtermsin
- Lalchungnunga
Dr Sirintra Nakjang
John Casement
Dr Laura Ogle
et al.
Identification of
TIAM1
as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellular Carcinoma
2023
Natassia Robinson
John Casement
Professor Roderick Skinner
Professor Linda Sharp
Dr Jill McKay
et al.
Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors
2022
Wen Hao
Professor Deborah Tweddle
Dr Ed Schwalbe
Dr Gordon Strathdee
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
2022
Dr Timothy Barrow
Dr Elaine Willmore
Dr Gordon Strathdee
Dr Hyang-Min Byun
Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukaemia
2021
Dr Timothy Barrow
Dr Sirintra Nakjang
Kateryna Bilotkach
Dr Laura Woodhouse
Gesa Junge
et al.
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia
2021
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Thahira Rahman
et al.
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
2021
Dr Ed Schwalbe
- Lalchungnunga
Dr Timothy Barrow
Dr Gordon Strathdee
Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets
2021
Professor Judith Rankin
Dr Gordon Strathdee
Dr Jill McKay
Exploring a potential mechanistic role of DNA methylation in the relationship between
in utero
and post-natal environmental exposures and risk of childhood acute lymphoblastic leukaemia
2019
Dr Kate Potter
Professor Anthony Moorman
Professor Caroline Relton
Professor John Mathers
Dr Gordon Strathdee
et al.
Maternal red blood cell folate and infant vitamin B12 status influence methylation of genes associated with childhood acute lymphoblastic leukaemia
2018
Jessica Timms
Professor Caroline Relton
Professor Judith Rankin
Dr Gordon Strathdee
Dr Jill McKay
et al.
DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukaemia
2016
Dr Timothy Barrow
Dr Laura Woodhouse
Gesa Junge
Dr Susan Tudhope
Dr Jonathan Wallis
et al.
The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy
2016
Sanne van Otterdijk
Jean Norden
Professor Anne Dickinson
Professor Mark Pearce
Professor Caroline Relton
et al.
Aberrations in DNA methylation are detectable during remission of acute lymphoblastic leukemia and predict patient outcome
2015
Dr Chris Smart
Dr Gordon Strathdee
Dr Stuart Watson
Professor Hamish McAllister-Williams
Early life trauma, depression and the glucocorticoid receptor gene - an epigenetic perspective
2015
Dr Al Gabriel
Fadhel Alsaid Naji
Dr Ed Schwalbe
Dr Sirintra Nakjang
Dr Simon Cockell
et al.
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia
2015
Dr Joanna Collerton
Hannah Gautrey
Sanne van Otterdijk
Dr Karen Davies
Dr Carmen Martin-Ruiz
et al.
Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+Study
2014
Hannah Gautrey
Sanne van Otterdijk
Professor Heather Cordell
Professor John Mathers
Dr Gordon Strathdee
et al.
DNA methylation abnormalities at gene promoters are extensive and variable in the elderly and phenocopy cancer cells
2014
Fadhel Alsaid Naji
Dr Vikki Rand
Professor Anthony Moorman
Dr Ed Schwalbe
Dr Amir Enshaei
et al.
Investigation of methylation based biomarkers for prediction of relapse in good prognostic cytogenetic subgroups of childhood acute lymphoblastic leukaemia
2014
Sanne van Otterdijk
Professor John Mathers
Dr Gordon Strathdee
Do age-related changes in DNA methylation play a role in the development of age-related diseases?
2013
Shabnam Thathia
Stuart Ferguson
Hannah Gautrey
Sanne Van Otterdijk
Dr Vikki Rand
et al.
Epigenetic inactivation of
TWIST2
in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity
2012
Dr Tryfonia Mainou-Fowler
Dr Gordon Strathdee
Methylation markers identify high risk patients in
IGHV
mutated chronic lymphocytic leukemia
2011
Dr Gordon Strathdee
Methylation markers in the clinical management of leukemia patients – Wave of the future or damp squib?
2011
Stuart Ferguson
Hannah Gautrey
Dr Gordon Strathdee
The Dual Role of HLXB9 in Leukemia
2011
Dr Gordon Strathdee
Stuart Ferguson
DNA methylation does not regulate JUNB expression in CML: Comment on "Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia" by Hoshino et al. [Leuk. Res. 33 (2009) 1361-1366]
2010
Professor John Mathers
Dr Gordon Strathdee
Professor Caroline Relton
Induction of Epigenetic Alterations by Dietary and Other Environmental Factors
2010
Dr Gordon Strathdee
HOXA5
is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia
2007
Dr Gordon Strathdee
Epigenetic markers and response to chemotherapy in cancer
2007
Dr Gordon Strathdee
Professor Anne Dickinson
HOX genes - Candidate tumor suppressor genes in adult, and childhood leukemia.
2007
Dr Gordon Strathdee
Professor Anne Dickinson
HOX genes are a major target for epigenetic mis-regulation in adult and childhood leukaemia
2007
Dr Gordon Strathdee
Professor Anne Dickinson
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis
2007
Dr Gordon Strathdee
Dr Laura Mackay
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors.
2007
Dr Janet Lindsey
Dr Meryl Lusher
Dr Gordon Strathdee
Robert Brown
Dr Richard Gilbertson
et al.
Epigenetic inactivation of
MCJ
(
DNAJD1
) in malignant paediatric brain tumours
2006
Dr Janet Lindsey
Dr Meryl Lusher
Dr Gordon Strathdee
Dr Richard Gilbertson
Professor Simon Bailey
et al.
Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours
2006
Dr Gordon Strathdee
Promoter hypermethylation silences expression of the
HoxA4
gene and correlates with IgVh mutational status in CLL
2006
Dr Gordon Strathdee
CpG island methylation of DNA damage response genes in advanced ovarian cancer
2005
Dr Gordon Strathdee
Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy
2005
Dr Gordon Strathdee
Bioscience 2004
2004
Dr Gordon Strathdee
Dr Barry Davies
Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene
2004
Dr Gordon Strathdee
Control of gene expression by CpG island methylation in normal cells
2004
Dr Gordon Strathdee
CpG-island methylation and epigenetic control of resistance to chemotherapy
2004
Dr Gordon Strathdee
Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker
2004
Dr Gordon Strathdee
Aberrant DNA methylation in cancer: potential clinical interventions
2002
Dr Gordon Strathdee
Epigenetic cancer therapies: DNA methyltransferase inhibitors
2002
Dr Gordon Strathdee
Epigenetic versus genetic alterations in the inactivation of E-cadherin
2002
Dr Gordon Strathdee
Epigenomics and epigenetic therapy of cancer
2002
Dr Gordon Strathdee
Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers
2002
Dr Gordon Strathdee
A role for mismatch repair in control of DNA ploidy following DNA damage
2001
Dr Gordon Strathdee
Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes
2001
Dr Gordon Strathdee
Julieann Sludden
Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter
2000
Dr Gordon Strathdee
A role for methylation of the
hMLH1
promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
1999
Dr Gordon Strathdee
Analysis of the
CAVEOLIN-1
gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines
1999